Aripiprazole was administered in an open-label manner at a starting dose of 5 to 15 mg/day at baseline.
A cylindrical phantom was filled with a homogeneous 2L water-FDG mixture at a starting dose of 301.2MBq.
The choice of vasoconstrictor therapy is normally that of terlipressin, with a starting dose of 0.5 mg 6 hourly and rising to 1 mg 6 hourly.
The drug has been uninterruptedly administered once a day in the evening (18 00 20 00), with a starting dose of 1.36 mg/day SQ.
or sorafenib at a starting dose of 400 mg b.i.d.
Of these, 78 patients were randomised to a starting dose of 20 mg per placebo.
60 consecutive PMR patients were treated with a starting dose of 12,5 mg/day prednisone.
The dose was escalated from a starting dose of 50 mg until the MTD was determined.
Axitinib was administered orally at a starting dose of 5 mg bid in 21-day cycles.
Patients were treated with sorafenib at a starting dose of 400 mg bid.
Insulin degludec is initiated at a starting dose of 10 units at bedtime.
